Glutamate Hypothesis of Schizophrenia and Approach for Possible Therapeutic Drugs

E-ISSN： 1875-6158|4|2|147-154

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.4, Iss.2, 2004-06, pp. : 147-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Glutamate Hypothesis of Schizophrenia: Neuroimaging and Drug Development

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1500-1512

Bentham Science Publishers

Access to resources Recommend Favorite

Ionotropic Glutamate Receptors as Therapeutic Targets in Schizophrenia

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 2, 2002-04 ,pp. : 183-189

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia

Current Pharmaceutical Design, Vol. 18, Iss. 12, 2012-04 ,pp. : 1580-1592

Bentham Science Publishers

Access to resources Recommend Favorite

PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 137-150

Bentham Science Publishers

Access to resources Recommend Favorite

The dopamine and glutamate hypotheses of schizophrenia -- therapeutic implications of an integrated view

By Carlsson A.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 160-160

Elsevier

Access to resources Recommend Favorite